AKT1 and cancer: These analyses have revealed features of RAS signaling, including activation of the MAPK and PI3K/Akt/mTORC1 pathways, as well as Wnt pathway signaling, cancer cell stemness, regulation of the actin cytoskeleton, and interaction with the ECM.